Crossref
FDA Approves New Medication for Agitation Associated With Dementia
JAMA · 16.06.2026 · 335 (23) · 2005
DOI: 10.1001/jama.2026.6193 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 16.06.2026. Verfasst von Samantha Anderer.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). FDA Approves New Medication for Agitation Associated With Dementia. JAMA, 335(23), 2005. https://doi.org/10.1001/jama.2026.6193
Vancouver
Anderer S. FDA Approves New Medication for Agitation Associated With Dementia. JAMA. 2026;335(23):2005. doi:10.1001/jama.2026.6193
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {FDA Approves New Medication for Agitation Associated With Dementia},
journal = {JAMA},
year = {2026},
volume = {335},
number = {23},
pages = {2005},
doi = {10.1001/jama.2026.6193}
}
EUVIMED